Tenon Medical, Inc. Sets Date for Second Quarter 2026 Earnings

Rhea-AI Summary

Tenon Medical (NASDAQ:TNON) will release its second quarter 2026 financial results for the period ended June 30, 2026 after market close on Thursday, August 13, 2026, followed by a conference call at 4:30 p.m. Eastern Time featuring a Q&A with covering analysts.

Investors can join via dial-in at 1-877-407-0792 (U.S.) or 1-201-689-8263 (international), or through a webcast titled “TNON Conference Call.” An audio replay will be available until August 27, 2026 on Tenon’s investor relations website or by telephone replay with access code 13761819.

According to Tenon Medical, the company develops medical devices for sacro-pelvic disorders and offers the Catamaran SI Joint Fusion System and, following an August 2025 asset acquisition from SiVantage and SIMPL Medical, the SImmetry+ SI Joint Fusion System.

Market Context

Comparable earnings-date notices produced reactions of 2.4% and -2.26%, adding a mixed historical ba...

Analysis

Comparable earnings-date notices produced reactions of 2.4% and -2.26%, adding a mixed historical baseline to this scheduling announcement. The recent $4.2 million public offering adds financing context to monitor alongside the results.

Key Figures

Earnings release date: August 13, 2026 Reporting period end: June 30, 2026 Conference call time: 4:30 p.m. Eastern Time +1 more

4 metrics

Earnings release date August 13, 2026 Second quarter 2026 results

Reporting period end June 30, 2026 Second quarter 2026

Conference call time 4:30 p.m. Eastern Time August 13, 2026

Replay availability August 27, 2026 Audio playback available through this date

Previous Earnings date Reports

2 past events · Latest: May 01 (Neutral)

Same Type Pattern 2 events

Date	Event	Sentiment	24h Move	Catalyst
May 01	Earnings date	Neutral	+2.4%	Scheduled first-quarter results and conference call for May 12
Feb 05	Earnings date	Neutral	-2.3%	Scheduled fourth-quarter and full-year results with revenue ranges

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Comparable earnings-date announcements produced mixed 24-hour reactions, with one positive and one negative outcome.

Key Terms

si joint

1 terms

si joint medical

"a diseased sacroiliac joint (the "SI Joint")"

The sacroiliac (SI) joint is the pair of joints where the sacrum at the base of the spine meets the pelvis, acting like a small shock‑absorbing hinge that transfers weight between the upper body and legs; dysfunction or injury can cause lower back, buttock, or leg pain. Investors see the SI joint in healthcare and device news because diagnostic tests, implants, surgical procedures, and drugs aimed at treating SI joint disorders can influence the sales, clinical trial results, and regulatory prospects of companies in orthopedics and pain management.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

LOS GATOS, CA / ACCESS Newswire / July 30, 2026 / Tenon Medical, Inc. (NASDAQ:TNON)("Tenon" or the "Company"), a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders, today announced plans to release financial results for the second quarter ended June 30, 2026 after market close on Thursday, August 13, 2026. The Company will also hold a conference call on the same day at 4:30 p.m. Eastern Time to discuss its financial results in further detail. The call will conclude with a Q&A session with its covering analysts.

Date:	Thursday, August 13, 2026
Time:	4:30 p.m. Eastern time
Dial-in:	1-877-407-0792
International Dial-in:	1-201-689-8263
Webcast:	TNON Conference Call

Please dial in at least 10 minutes before the start of the call to ensure timely participation.

An audio playback of the call will be available through August 27, 2026,on Tenon's Investor Relations website at http://ir.tenonmed.com/ or via telephone replay by dialing 1-844-512-2921 (USA) or 1-412-317-6671(International). The access code will be 13761819.

About Tenon Medical, Inc.

Tenon Medical, Inc. is a medical device company dedicated to transforming care for patients with certain sacro-pelvic disorders. Tenon was incorporated in the State of Delaware in 2012 and currently offers two systems to treat a diseased sacroiliac joint (the "SI Joint"). The Company has developed The Catamaran^™ SI Joint Fusion System that offers a novel, less invasive approach to the SI Joint using a single, robust titanium implant. In August 2025, the Company acquired substantially allof the assets of SiVantage, Inc. and SIMPL Medical, LLC, including the SImmetry+^® SI Joint Fusion System, which treats disorders of the SI Joint through a minimally invasive lateral access solution that incorporates well-established orthopedic fusion principles. Since the national launch of The Catamaran System in October 2022, Tenon is focused on three commercial opportunities: 1) primary SI Joint procedures, 2) revision procedures of failed SI Joint implants and 3) SI-Joint fusion adjunct to a spine fusion construct.

For more information, please visit www.tenonmed.com. Information on the Company's website does not constitute a part of and is not incorporated by reference into this press release.

The Tenon Medical logo shown above, and Catamaran^®, PiSIF^®, CAT PiSIF^®, ETAD^®, Posterior Inferior Sacroiliac Fusion^®, CAT SIJ Fusion System^®, Catamaran SIJ Fusion System^®, Catamaran Inferior Posterior Fusion System^®, Catamaran Transfixation Fusion System^®, Catamaran Transfixation Fusion Device^®, SImmetry^® are registered trademarks of Tenon Medical, Inc. MAINSAIL^TM, and SImmetry+ are also trademarks of Tenon Medical, Inc.

IR Contact:
Shannon Devine
203-741-8811
MZ North America
tenon@mzgroup.us

SOURCE: Tenon Medical, Inc.

View the original press release on ACCESS Newswire

FAQ

When will Tenon Medical (NASDAQ:TNON) report its Q2 2026 earnings?

Tenon Medical will report Q2 2026 earnings on Thursday, August 13, 2026 after market close. According to Tenon Medical, the results cover the quarter ended June 30, 2026 and will be discussed on a conference call later that afternoon.

What time is Tenon Medical's Q2 2026 earnings conference call and how do I join?

The Tenon Medical Q2 2026 earnings call starts at 4:30 p.m. Eastern Time on August 13, 2026. According to Tenon Medical, investors can dial 1-877-407-0792 (U.S.) or 1-201-689-8263 (international), or access the “TNON Conference Call” webcast.

How can I listen to the replay of Tenon Medical's (TNON) Q2 2026 earnings call?

A replay of Tenon Medical's Q2 2026 earnings call will be available through August 27, 2026. According to Tenon Medical, investors can access it via the investor relations website or by dialing 1-844-512-2921 (U.S.) or 1-412-317-6671 (international), using access code 13761819.

What does Tenon Medical (TNON) do in the sacroiliac (SI) joint market?

Tenon Medical develops medical devices for certain sacro-pelvic disorders, focusing on the sacroiliac joint. According to Tenon Medical, it offers the Catamaran SI Joint Fusion System and the SImmetry+ SI Joint Fusion System for primary, revision, and adjunct SI joint fusion procedures.

What assets did Tenon Medical acquire from SiVantage and SIMPL Medical in August 2025?

In August 2025, Tenon Medical acquired substantially all assets of SiVantage and SIMPL Medical. According to Tenon Medical, the deal included the SImmetry+ SI Joint Fusion System, a minimally invasive lateral access solution incorporating established orthopedic fusion principles for sacroiliac joint disorders.

How can investors contact Tenon Medical investor relations about the Q2 2026 earnings call?

Investors can contact Tenon Medical’s investor relations through Shannon Devine at 203-741-8811 or by email at tenon@mzgroup.us. According to Tenon Medical, these IR contacts are provided for shareholder and analyst inquiries related to events such as the Q2 2026 earnings call.